Maia Biotechnology Inc

Maia Biotechnology Inc has a negative equity position of -$5.76 million and a market cap of $82.51 million, indicating a high degree of financial leverage and a speculative valuation. The company's liquidity position is characterized by a current ratio of 1.77, suggesting it can cover its short-term liabilities with its current assets, but its total liabilities of $14.48 million exceed its total assets of $8.72 million, indicating a net liability position. The company's profitability is negative, with a net loss of $8.07 million and an operating loss of $3.95 million. Its return on equity is 1.3994, which is unusually high given the negative equity, and its return on assets is -0.9256, indicating poor asset utilization. These metrics are not directly comparable to industry medians due to the absence of industry_config data for this company. Maia Biotechnology Inc's revenue concentration and geographic exposure are not disclosed in the available data. The company does not provide segment-specific financials, and its operating cash flow of -$3.59 million suggests it is not generating positive cash from operations. The absence of long-term debt indicates the company is not leveraging debt to fund operations, but this also suggests limited financial flexibility. The company's growth trajectory is not quantified in the available data, but its negative operating and net income suggest it is not currently profitable. Analysts have assigned a mean price target of $12.13, with a median of $12.13 and a high of $14.00, indicating a potential upside from the current market price of $1.36. However, the absence of revenue history makes it difficult to assess the company's growth potential. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's dilution potential is low, and its capital structure does not show signs of recent or planned equity issuance. The absence of long-term debt and the low dilution risk suggest the company is not currently under financial pressure to raise additional capital. Recent events and filings for Maia Biotechnology Inc are not detailed in the available data. The company's financial snapshot does not include specific events or transcripts, and the risk assessment does not flag any recent developments that would impact its financial position. The absence of detailed recent events makes it difficult to assess the company's current strategic direction or operational performance.